Quick read
Fair Value Engine
Decision-focused synthesis of expected stock prices combining relative peer multiples and intrinsic models.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot
RH stock price vs AZO: inconclusive
Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Price gap
N/A
Coverage
Medium · 60%
Free account · revisit it from your workspace
Quick read
Decision-focused synthesis of expected stock prices combining relative peer multiples and intrinsic models.
Latest stored price
Metric-by-metric
Filter, sort, and scan where each company leads, where gaps are small, and where comparisons are not meaningful.
| Metric | RH | AZO | Spread |
|---|---|---|---|
Revenue growth (YoY) RH: FY 2025 -> FY 2026 | AZO: FY 2024 -> FY 2025 | 8.1% | 2.4% | RH leads by 235.5% Higher Revenue growth |
Gross margin | 44.1% | 52.6% | AZO leads by 16.3% Higher Gross margin |
EBITDA margin | 22.0% | 20.4% | RH leads by 7.4% Higher EBITDA margin |
EV/Revenue | N/M | N/M | Insufficient data No additional context |
P/E | N/M | N/M | Not comparable Not comparable |
Net debt / EBITDA | -0.2 | 2.2 | RH leads by 110.9% Lower Net debt / EBITDA |
Statements
Core income statement and balance sheet metrics aligned to the reporting windows.
| Metric | RH | Delta vs AZO | AZO |
|---|---|---|---|
| Revenue | $3.44B | 81.8% lower | $18.94B |
| Gross profit | $1.52B | 84.8% lower | $9.97B |
| Operating income | $387.27M | 89.3% lower | $3.61B |
| EBITDA | $755.50M | 80.5% lower | $3.87B |
| Net income | $124.79M | 95.0% lower | $2.50B |
| EPS | 6.3 | 95.6% lower | 144.9 |
| Revenue growth | 8.1% | 235.5% higher | 2.4% |
| Gross margin | 44.1% | 16.3% lower | 52.6% |
| Operating margin | 11.3% | 40.9% lower | 19.1% |
| EBITDA margin | 22.0% | 7.4% higher | 20.4% |
| Net margin | 3.6% | 72.5% lower | 13.2% |
Trendline
Track multi-year revenue, earnings, and margin direction before underwriting a rerating.
Price framework
Market cap + debt - cash, shown for the current pair and benchmark median context.
Price framework
Baseline discounted cash flow model estimating total intrinsic firm value first, then bridging to an implied stock price per share.
Risk control
Financial health checks to separate durable balance sheets from potential value traps.
Comparable set
Place both companies in context relative to a wider comparable universe.
LLM-powered Synthesis
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
RH screens as expensive versus AZO-implied value and its own fundamental quality, with the current price 20.6% above implied value despite weaker profitability and much poorer balance-sheet quality than AZO.
If you believe RH can materially improve margins and capital efficiency toward AZO-like quality, then the stock could deserve a higher multiple; otherwise, the data argue for caution or underweighting RH because the current price sits 20.6% above AZO-implied value and quality metrics remain weak.
RH’s current price of $165.52 is 20.6% above the P/E-implied value of $131.38, indicating the stock is priced rich relative to this AZO-based framework. The gap is especially notable because RH’s P/E multiple is higher than AZO’s despite RH having materially weaker margins and returns.
Supporting Metrics